BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
105 results:

  • 1. A senescence restriction point acting on chromatin integrates oncogenic signals.
    Lopes-Paciencia S; Bourdeau V; Rowell MC; Amirimehr D; Guillon J; Kalegari P; Barua A; Quoc-Huy Trinh V; Azzi F; Turcotte S; Serohijos A; Ferbeyre G
    Cell Rep; 2024 Apr; 43(4):114044. PubMed ID: 38568812
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian cancer.
    Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
    JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic pancreatic cancer: A Systematic Review and Meta-Analysis.
    Nichetti F; Rota S; Ambrosini P; Pircher C; Gusmaroli E; Droz Dit Busset M; Pusceddu S; Sposito C; Coppa J; Morano F; Pietrantonio F; Di Bartolomeo M; Mariani L; Mazzaferro V; de Braud F; Niger M
    JAMA Netw Open; 2024 Jan; 7(1):e2350756. PubMed ID: 38190183
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effect of Laparoscopic and Open pancreaticoduodenectomy for pancreatic or Periampullary Tumors: Three-year Follow-up of a Randomized Clinical Trial.
    Qin T; Zhang H; Pan S; Liu J; Li D; Chen R; Huang X; Liu Y; Liu J; Cheng W; Chen X; Zhao W; Li J; Tan Z; Huang H; Li D; Zhu F; Yu G; Zhou B; Zheng S; Tang Y; Ke J; Liu X; Chen B; Chen W; Ma H; Xu J; Liu Y; Lin R; Dong Y; Yu Y; Wang M; Qin R;
    Ann Surg; 2024 Apr; 279(4):605-612. PubMed ID: 37965767
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning.
    Tharmaseelan H; Vellala AK; Hertel A; Tollens F; Rotkopf LT; Rink J; Woźnicki P; Ayx I; Bartling S; Nörenberg D; Schoenberg SO; Froelich MF
    Cancer Imaging; 2023 Oct; 23(1):95. PubMed ID: 37798797
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Combination of runx1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.
    She C; Wu C; Guo W; Xie Y; Li S; Liu W; Xu C; Li H; Cao P; Yang Y; Wang X; Chang A; Feng Y; Hao J
    J Exp Clin Cancer Res; 2023 Sep; 42(1):238. PubMed ID: 37697370
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Major dietary patterns in the United Kingdom Women's Cohort Study showed no evidence of prospective association with pancreatic cancer risk.
    Shyam S; Greenwood DC; Mai CW; Tan SS; Yusof BM; Moy FM; Cade JE
    Nutr Res; 2023 Oct; 118():41-51. PubMed ID: 37562156
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Minimally invasive distal pancreatectomy for adenocarcinoma of the pancreas.
    Nicolais L; Mohamed A; Fitzgerald TL
    Surg Oncol; 2023 Oct; 50():101970. PubMed ID: 37459676
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Construction and external validation of a nomogram model for predicting the risk of esophageal stricture after endoscopic submucosal dissection: a multicenter case-control study.
    Mu Z; Tang X; Wang J; Chen Y; Cui K; Rao X; Li J; Yang G
    BMC Gastroenterol; 2023 Jul; 23(1):226. PubMed ID: 37393226
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. cancer survival analysis and spatial distribution during 2014-2016 in Shandong Province, China.
    Jiang F; Fu Z; Lu Z; Chu J; Xu A; Guo X; Ma J
    Sci Rep; 2023 Jun; 13(1):10324. PubMed ID: 37365230
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study.
    Pan Y; Zhu X; Liu J; Zhong J; Zhang W; Shen S; Jin R; Liu H; Ye F; Hu K; Xu D; Zhang Y; Chen Z; Xing B; Zhou L; Chen Y; Zeng Y; Liang X; Kuang M; Song T; Xiang B; Wang K; Sun H; Xu L;
    Front Immunol; 2023; 14():1138355. PubMed ID: 37180173
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic proxies for calcium channel blockers and cancer: a Mendelian randomization study.
    Fan B; Schooling CM; Zhao JV
    J Hum Hypertens; 2023 Nov; 37(11):1028-1032. PubMed ID: 37117874
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial.
    Waterhouse M; Ebeling PR; McLeod DSA; English D; Romero BD; Baxter C; Armstrong BK; Hartel G; Kimlin M; O'Connell RL; van der Pols JC; Venn AJ; Webb PM; Whiteman DC; Neale RE
    Lancet Diabetes Endocrinol; 2023 May; 11(5):324-332. PubMed ID: 37011645
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Systemic deuteration of SCID mice using the water-isotopologue deuterium oxide (D
    Jandova J; Galons JP; Dettman DL; Wondrak GT
    Mol Carcinog; 2023 May; 62(5):598-612. PubMed ID: 36727657
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-term outcomes of endoscopic papillectomy for ampullary adenoma with high-grade dysplasia or adenocarcinoma: a propensity score-matched analysis.
    Yoon SB; Jung MK; Lee YS; Park JK; Jang DK; Lee JM; Lee HS; Shin DW; Lee JC; Hwang JH
    Surg Endosc; 2023 May; 37(5):3522-3530. PubMed ID: 36587061
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women.
    Peduzzi G; Archibugi L; Katzke V; Gentiluomo M; Capurso G; Milanetto AC; Gazouli M; Goetz M; Brenner H; Vermeulen RCH; Talar-Wojnarowska R; Vanella G; Tavano F; Lucchesi M; Mohelnikova-Duchonova B; Chen X; Kiudelis V; Hegyi P; Oliverius M; Stocker H; Stornello C; Vodickova L; Souček P; Neoptolemos JP; Testoni SGG; Morelli L; Lawlor RT; Basso D; Izbicki JR; Ermini S; Kupcinskas J; Pezzilli R; Boggi U; van Laarhoven HWM; Szentesi A; Erőss B; Capretti G; Schöttker B; Skieceviciene J; Aoki MN; van Eijck CHJ; Cavestro GM; Canzian F; Campa D
    Sci Rep; 2022 Oct; 12(1):18100. PubMed ID: 36302831
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
    Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
    Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [The clinical value of classification of hilar cholangiocarcinoma based on actual anatomy].
    Peng SY; Liu YB; Li XS; Wu Y; Jin YQ; Yu XA; Wang W; Gong W
    Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):860-865. PubMed ID: 36058713
    [No Abstract]    [Full Text] [Related]  

  • 19. Increased incidence of indeterminate pancreatic cysts and changes of management pattern: Evidence from nationwide data.
    Park J; Park J; Lee YS; Jung K; Jung IH; Lee JC; Hwang JH; Kim J
    Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):294-301. PubMed ID: 35715339
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic value of inflammation-immunity-nutrition score in patients with hepatocellular carcinoma treated with anti-PD-1 therapy.
    Zhang Z; Liang Y; Zhong D; Dai Z; Shang J; Lai C; Zou H; Yao Y; Feng T; Huang X
    J Clin Lab Anal; 2022 May; 36(5):e24336. PubMed ID: 35312116
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.